# US 2015/0104427 A1 · Enzyme-assisted spatial decoration of biomaterials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104427 A1
- Document ID: US20150104427A1
- Status: Published application
- Kind: A1
- Application number: 14/357,545
- Filed: 2012-11-09
- Published: 2015-04-16
- Earliest claimed: 2011-11-10
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Tatiana Segura
- Web page: https://patentgrep.com/patent/US20150104427A1

## CPC

- A61K 38/45: Transferases (2)
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/20: Polysaccharides
- A61L 27/36: containing ingredients of undetermined constitution or reaction products thereof {, e.g. transplant tissue, natural bone, extracellular matrix (isolated natural compounds, e.g. collagen A61L27/24)}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- C08H 1/00: Macromolecular products derived from proteins (food proteins A23; glue, gelatine C09H)
- C08J 3/075: Macromolecular gels
- C08J 3/246: {Intercrosslinking of at least two polymers}
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08L 71/02: Polyalkylene oxides
- C08L 89/00: Compositions of proteins; Compositions of derivatives thereof
- C12N 9/99: Enzyme inactivation by chemical treatment
- C12N 11/04: entrapped within the carrier, e.g. gel or hollow fibres
- C12N 11/089: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C08J 2305/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08J 2371/02: Polyalkylene oxides
- C08J 2389/00: Characterised by the use of proteins; Derivatives thereof
- C12Y 203/02013: Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- C08H: DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS (polysaccharides C08B; natural rubber C08C; natural resins or their derivatives C09F; bituminous materials C10)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

A method of producing a hydrogel compromising a spatially-controlled, three-dimensional distribution of one or more bioactive signals is provided. The method compromises illuminating the hydrogel, wherein the hydrogel compromises a polymer bound to a peptide comprising a photolabile protected amino acid, wherein at least one portion of the hydrogel is illuminated to deprotect the protected amino acid, thereby converting the protected amino acid to a deprotected amino acid. Preferably, the deprotected amino acid is a substrate for an enzyme in at least one portion of the hydrogel. The method further comprises the step of contacting the hydrogel with the enzyme and a peptide comprising a bioactive signal, wherein the enzyme can form a bond between the substrate and the peptide comprising the bioactive signal, thereby producing a hydrogel compromising a plurality of bioactive signals occupying three dimensions of the hydrogel within at least one portion of the hydrogel subjected to illumination.

## Claims

### Claim 1

A method of producing a hydrogel comprising a spatially-controlled, three-dimensional distribution of one or more bioactive signals compromising:
a. illuminating the hydrogel, wherein the hydrogel comprises a polymer bound to a peptide comprising a photolabile protected amino acid, wherein at least a portion of the hydrogel is illuminated to deprotect the photolabile protected amino acid, thereby converting the photolabile protected amino acid to a deprotected amino acid, wherein the deprotected amino acid is a substrate for an enzyme in at least one portion of the hydrogel;
b. contacting the hydrogel with the enzyme and a bioactive signal, wherein the enzyme can form a bond between the substrate and the bioactive signal, thereby producing a hydrogel comprising a plurality of bioactive signals occupying three dimensions of the hydrogel within at least one portion of the hydrogel subjected to illumination.

### Claim 2 (depends on 1)

The method of claim 1, wherein the polymer comprises hyaluronic acid and/or poly(ethylene glycol).

### Claim 3 (depends on 1)

The method of claim 1, wherein the photolabile protected amino acid is a caged amino acid selected from the group consisting of lysine (K), aspartic acid (D), glutamic acid (E), arginine (R), serine (S), tyrosine (Y), and cysteine (C).

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The method of claim 1, wherein the bond is a covalent bond.

### Claim 6 (depends on 1)

The method of claim 1, wherein the enzyme comprises a transglutaminase.

### Claim 7 (depends on 6)

The method of claim 6, wherein the enzyme is Factor XIIIa.

### Claim 8 (depends on 1)

The method of claim 1, wherein the bioactive signal is selected from the group consisting of an amino acid glutamine (Q) linked to an amino acid motif RGD, an amino acid glutamine (Q) linked to one or more fibronectin fragments, and fibronectin or a fragment thereof.

### Claim 9

(canceled)

### Claim 10 (depends on 3)

The method of claim 3, wherein the caged amino acid comprises an ortho-nitrobenzyl photoactive chemical moiety.

### Claim 11 (depends on 7)

The method of claim 7, wherein the enzyme Factor XIIIa catalyzes a transamination reaction between the deprotected amino acid and the amino acid glutamine (Q) linked to the amino acid motif RGD, thereby immobilizing the bioactive signal to the hydrogel.

### Claim 12

A method of producing a hydrogel, the method comprising:
a. illuminating the hydrogel, wherein the hydrogel comprises a polymer bound to a photolabile protected peptide, and wherein one or more portions of the hydrogel is illuminated to deprotect the photolabile protected peptide, thereby converting the photolabile protected peptide to a deprotected peptide, wherein the deprotected peptide is a substrate for an enzyme in one or more portions of the hydrogel.

### Claim 13 (depends on 12)

The method of claim 12, wherein the deprotected peptide is degraded within one or more portions of the hydrogel subjected to illumination.

### Claim 14 (depends on 12)

The method of claim 12, wherein the peptide is a protease degradable peptide and/or comprises at least one protease cleavage site.

### Claim 15 (depends on 14)

The method of claim 14, wherein the peptide selected from the group consisting of a MMP degradable peptide and a peptide degradable by trypsin or plasmin.

### Claim 16 (depends on 12)

The method of claim 12, wherein the enzyme is selected from the group consisting of a protease, trypsin, and plasmin.

### Claim 17 (depends on 16)

The method of claim 16, wherein the enzyme is a MMP protease.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20 (depends on 12)

The method of claim 12, wherein the peptide comprises a protease cleavage site, wherein cleavage at said site releases a bioactive signal.

### Claim 21 (depends on 1, 12)

The method of claim 1 or 12, further comprising the step of seeding the hydrogel with cells.

### Claim 22 (depends on 1)

The method of claim 1, wherein the bioactive signal is one or more growth factors selected from the group consisting of VEGF and PDGF.

### Claim 23

(canceled)

### Claim 24

(canceled)

### Claim 25 (depends on 1)

A hydrogel produced by the method of claim 1.

### Claim 26 (depends on 12)

A hydrogel produced by the method of claim 12.

### Claim 27

A hydrogel compromising:
a. a spatially-controlled, three-dimensional distribution of one or more bioactive signals, wherein the bioactive signals are the same or different.

### Claim 28 (depends on 1, 12)

A method of controlling cellular migration and/or introducing tunnels into hydrogels, comprising producing the hydrogel of claim 1 or 12.

### Claim 29

(canceled)
